What We Do
Investment Banking
Based on our extensive expertise, we advise clients on a variety of complex transactions and novel deal structures, including:
- global strategic alliances, joint ventures and collaborations;
- business development and licensing support for both out-license and in-license assets depending upon the requirements;
- co-development, co-commercialization, co-promotion and marketing agreements;
- commercial and technical due diligence; asset valuation and positioning, target screening;
- deal structuring, comparable analysis, term sheet analysis and negotiation, deal closure.
Merger and Acquisition
We support our clients to achieve excellence by providing trusted strategic advice, capital raising and risk management services with a global perspective, and professional insights into the Chinese market in respect of the specific sectors. The service encompasses two areas: sell-side advice and merger transactions.Biotech License-in/out
We are a leading advisor on licensing deals from early-stage to late-stage novel products for significant unmet medical needs. We bring value to our clients making license-in and out deals involving early and late development stage products, approved products and platform technologies specific to the biotech sector.Based on our extensive expertise, we advise clients on a variety of complex transactions and novel deal structures, including:
- global strategic alliances, joint ventures and collaborations;
- business development and licensing support for both out-license and in-license assets depending upon the requirements;
- co-development, co-commercialization, co-promotion and marketing agreements;
- commercial and technical due diligence; asset valuation and positioning, target screening;
- deal structuring, comparable analysis, term sheet analysis and negotiation, deal closure.